Referenced Items are not available for this document.
Various silk based drug delivery systems were designed to exploit silk's novel material properties in order to attain slow, sustained, controlled release. Using the small molecule model drug adenosine, release profiles from various silk delivery systems were characterized in vitro. The therapeutic potential of the implants was validated in a dose response study in the rat model of kindling epileptogenesis. Adenosine releasing silk implants engineered to release varied target release doses were implanted in rat brains and dose-dependent delays in epileptogenesis were observed over 14 days. We conclude that silk-based adenosine delivery systems represent a safe and efficient strategy to suppress seizures, and that these degradable, implantable biomaterials could potentially be applied to a range of therapeutics.
Published in:
Bioengineering Conference, 2009 IEEE 35th Annual Northeast
Date of Conference: 3-5 April 2009
- Page(s):
- 1 - 2
- E-ISBN :
- 978-1-4244-4364-2
- Print ISBN:
- 978-1-4244-4362-8
- INSPEC Accession Number:
- 10666507
- Conference Location :
- Boston, MA
- Digital Object Identifier :
- 10.1109/NEBC.2009.4967659
- Product Type:
- Conference Publications
About IEEE Xplore | Contact | Help | Terms of Use | Nondiscrimination Policy | Site Map | Privacy & Opting Out of Cookies
A not-for-profit organization, IEEE is the world's largest professional association for the advancement of technology.
© Copyright 2013 IEEE - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.
